当前位置: 首页 >> 检索结果
共有 5676 条符合本次的查询结果, 用时 3.7611649 秒

341. Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.

作者: Melinda J Hamer.;Katherine V Houser.;Amelia R Hofstetter.;Ana M Ortega-Villa.;Christine Lee.;Anne Preston.;Brooke Augustine.;Charla Andrews.;Galina V Yamshchikov.;Somia Hickman.;Steven Schech.;Jack N Hutter.;Paul T Scott.;Paige E Waterman.;Mihret F Amare.;Victoria Kioko.;Casey Storme.;Kayvon Modjarrad.;Melanie D McCauley.;Merlin L Robb.;Martin R Gaudinski.;Ingelise J Gordon.;LaSonji A Holman.;Alicia T Widge.;Larisa Strom.;Myra Happe.;Josephine H Cox.;Sandra Vazquez.;Daphne A Stanley.;Tamar Murray.;Caitlyn N M Dulan.;Ruth Hunegnaw.;Sandeep R Narpala.;Phillip A Swanson.;Manjula Basappa.;Jagada Thillainathan.;Marcelino Padilla.;Britta Flach.;Sarah O'Connell.;Olga Trofymenko.;Patricia Morgan.;Emily E Coates.;Jason G Gall.;Adrian B McDermott.;Richard A Koup.;John R Mascola.;Aurélie Ploquin.;Nancy J Sullivan.;Julie A Ake.;Julie E Ledgerwood.; .
来源: Lancet. 2023年401卷10373期294-302页
WHO has identified Marburg virus as an emerging virus requiring urgent vaccine research and development, particularly due to its recent emergence in Ghana. We report results from a first-in-human clinical trial evaluating a replication-deficient recombinant chimpanzee adenovirus type 3 (cAd3)-vectored vaccine encoding a wild-type Marburg virus Angola glycoprotein (cAd3-Marburg) in healthy adults.

343. Efficacy of pyriproxyfen-pyrethroid long-lasting insecticidal nets (LLINs) and chlorfenapyr-pyrethroid LLINs compared with pyrethroid-only LLINs for malaria control in Benin: a cluster-randomised, superiority trial.

作者: Manfred Accrombessi.;Jackie Cook.;Edouard Dangbenon.;Boulais Yovogan.;Hilaire Akpovi.;Arthur Sovi.;Constantin Adoha.;Landry Assongba.;Aboubacar Sidick.;Bruno Akinro.;Razaki Ossè.;Filémon Tokponnon.;Rock Aïkpon.;Aurore Ogouyemi-Hounto.;Germain Gil Padonou.;Immo Kleinschmidt.;Louisa A Messenger.;Mark Rowland.;Corine Ngufor.;Natacha Protopopoff.;Martin C Akogbeto.
来源: Lancet. 2023年401卷10375期435-446页
New classes of long-lasting insecticidal nets (LLINs) combining mixtures of insecticides with different modes of action could put malaria control back on track after rebounds in transmission across sub-Saharan Africa. We evaluated the relative efficacy of pyriproxyfen-pyrethroid LLINs and chlorfenapyr-pyrethroid LLINs compared with standard LLINs against malaria transmission in an area of high pyrethroid resistance in Benin.

344. Human security and universal health coverage: Japan's vision for the G7 Hiroshima Summit.

作者: Fumio Kishida.
来源: Lancet. 2023年401卷10373期246-247页

345. One Health action for health security and equity.

作者: .
来源: Lancet. 2023年401卷10376期530-533页

346. Convexity subarachnoid haemorrhage - Authors' reply.

作者: Jan Claassen.;Soojin Park.
来源: Lancet. 2023年401卷10372期194页

347. Who really benefits from drug combinations and long titrations for pain? - Authors' reply.

作者: Solomon Tesfaye.;Gordon Sloan.;David White.;Mike Bradburn.;Didier Bouhassira.;Dinesh Selvarajah.; .
来源: Lancet. 2023年401卷10372期192-193页

348. Digitising tremor.

作者: Scott L Delp.;Eric J Topol.
来源: Lancet. 2023年401卷10372期187页

349. COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy.

作者: Sascha Ellington.;Tara C Jatlaoui.
来源: Lancet. 2023年401卷10375期412-413页

350. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.

作者: Jose Villar.;Constanza P Soto Conti.;Robert B Gunier.;Shabina Ariff.;Rachel Craik.;Paolo I Cavoretto.;Stephen Rauch.;Serena Gandino.;Ricardo Nieto.;Adele Winsey.;Camilla Menis.;Gabriel B Rodriguez.;Valeria Savasi.;Niyazi Tug.;Sonia Deantoni.;Marta Fabre.;Begoña Martinez de Tejada.;Maria Jose Rodriguez-Sibaja.;Stefania Livio.;Raffaele Napolitano.;Nerea Maiz.;Helena Sobrero.;Ashley Peterson.;Philippe Deruelle.;Carolina Giudice.;Jagjit S Teji.;Roberto A Casale.;Laurent J Salomon.;Federico Prefumo.;Leila Cheikh Ismail.;Michael G Gravett.;Marynéa Vale.;Valeria Hernández.;Loïc Sentilhes.;Sarah R Easter.;Carola Capelli.;Emily Marler.;Daniela M Cáceres.;Guadalupe Albornoz Crespo.;Ernawati Ernawati.;Michal Lipschuetz.;Ken Takahashi.;Carmen Vecchiarelli.;Teresa Hubka.;Satoru Ikenoue.;Gabriela Tavchioska.;Babagana Bako.;Adejumoke I Ayede.;Brenda Eskenazi.;Jim G Thornton.;Zulfiqar A Bhutta.;Stephen H Kennedy.;Aris T Papageorghiou.; .
来源: Lancet. 2023年401卷10375期447-457页
In 2021, we showed an increased risk associated with COVID-19 in pregnancy. Since then, the SARS-CoV-2 virus has undergone genetic mutations. We aimed to examine the effects on maternal and perinatal outcomes of COVID-19 during pregnancy, and evaluate vaccine effectiveness, when omicron (B.1.1.529) was the variant of concern.

351. COVID-19 and other pandemics require a coherent response strategy.

作者: Michael G Baker.;David Durrheim.;Li Yang Hsu.;Nick Wilson.
来源: Lancet. 2023年401卷10373期265-266页

352. Stopping epidemics when and where they occur.

作者: Els Torreele.;Michel Kazatchkine.;Joanne Liu.;Mark Dybul.;Mauricio Cárdenas.;Sudhvir Singh.;Helena Legido Quigley.;Christine McNab.;Ellen Johnson Sirleaf.;Mariana Mazzucato.;Helen Clark.
来源: Lancet. 2023年401卷10374期324-328页

354. Medical education reforms in China.

作者: Jie Qiao.;Yuanyuan Wang.;Fei Kong.;Yu Fu.
来源: Lancet. 2023年401卷10371期103-104页

355. Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland.

作者: Holly Tibble.;Tanja Mueller.;Euan Proud.;Elliott Hall.;Amanj Kurdi.;Chris Robertson.;Marion Bennie.;Lana Woolford.;Aziz Sheikh.
来源: Lancet. 2023年401卷10371期101-102页

356. PANORAMIC: important insights into molnupiravir use in COVID-19.

作者: Michael R Kidd.;Paul M Kelly.
来源: Lancet. 2023年401卷10373期250-251页

357. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.

作者: Christopher C Butler.;F D Richard Hobbs.;Oghenekome A Gbinigie.;Najib M Rahman.;Gail Hayward.;Duncan B Richards.;Jienchi Dorward.;David M Lowe.;Joseph F Standing.;Judith Breuer.;Saye Khoo.;Stavros Petrou.;Kerenza Hood.;Jonathan S Nguyen-Van-Tam.;Mahendra G Patel.;Benjamin R Saville.;Joe Marion.;Emma Ogburn.;Julie Allen.;Heather Rutter.;Nick Francis.;Nicholas P B Thomas.;Philip Evans.;Melissa Dobson.;Tracie-Ann Madden.;Jane Holmes.;Victoria Harris.;May Ee Png.;Mark Lown.;Oliver van Hecke.;Michelle A Detry.;Christina T Saunders.;Mark Fitzgerald.;Nicholas S Berry.;Lazaro Mwandigha.;Ushma Galal.;Sam Mort.;Bhautesh D Jani.;Nigel D Hart.;Haroon Ahmed.;Daniel Butler.;Micheal McKenna.;Jem Chalk.;Layla Lavallee.;Elizabeth Hadley.;Lucy Cureton.;Magdalena Benysek.;Monique Andersson.;Maria Coates.;Sarah Barrett.;Clare Bateman.;Jennifer C Davies.;Ivy Raymundo-Wood.;Andrew Ustianowski.;Andrew Carson-Stevens.;Ly-Mee Yu.;Paul Little.; .
来源: Lancet. 2023年401卷10373期281-293页
The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. We aimed to establish whether the addition of molnupiravir to usual care reduced hospital admissions and deaths associated with COVID-19 in this population.

358. Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts.

作者: Iain S Forrest.;Ben O Petrazzini.;Áine Duffy.;Joshua K Park.;Carla Marquez-Luna.;Daniel M Jordan.;Ghislain Rocheleau.;Judy H Cho.;Robert S Rosenson.;Jagat Narula.;Girish N Nadkarni.;Ron Do.
来源: Lancet. 2023年401卷10372期215-225页
Binary diagnosis of coronary artery disease does not preserve the complexity of disease or quantify its severity or its associated risk with death; hence, a quantitative marker of coronary artery disease is warranted. We evaluated a quantitative marker of coronary artery disease derived from probabilities of a machine learning model.

359. The Lancet Commission on 21st-Century Global Health Threats.

作者: Natalia Kanem.;Christopher J L Murray.;Richard Horton.
来源: Lancet. 2023年401卷10370期10-11页

360. A call to accelerate an end to human rabies deaths.

作者: S M Thumbi.;Lucille Blumberg.;Kevin le Roux.;Naseem Salahuddin.;Bernadette Abela.
来源: Lancet. 2022年400卷10369期2261-2264页
共有 5676 条符合本次的查询结果, 用时 3.7611649 秒